| 1EUB | A: | SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED TO A POTENT NON-PEPTIDIC SULFONAMIDE INHIBITOR |
| 1FLS | A: | SOLUTION STRUCTURE OF THE CATALYTIC FRAGMENT OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED WITH A HYDROXAMIC ACID INHIBITOR |
| 1FM1 | A: | SOLUTION STRUCTURE OF THE CATALYTIC FRAGMENT OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED WITH A HYDROXAMIC ACID INHIBITOR |
| 1XUC | A:; B: | MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR |
| 1XUD | A:; B: | MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR |
| 1XUR | A:; B: | MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR |
| 1YOU | A:; B: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH A POTENT PYRIMIDINETRIONE INHIBITOR |
| 1ZTQ | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH WAY-033 |
| 2D1N | A:; B: | COLLAGENASE-3 (MMP-13) COMPLEXED TO A HYDROXAMIC ACID INHIBITOR |
| 2E2D | A: | FLEXIBILITY AND VARIABILITY OF TIMP BINDING: X-RAY STRUCTURE OF THE COMPLEX BETWEEN COLLAGENASE-3/MMP-13 AND TIMP-2 |
| 2OW9 | A:; B: | CRYSTAL STRUCTURE ANALYSIS OF THE MMP13 CATALYTIC DOMAIN IN COMPLEX WITH SPECIFIC INHIBITOR |
| 2OZR | A:; B:; C:; D:; E:; F:; G:; H: | MMP13 CATALYTIC DOMAIN COMPLEXED WITH 4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID |
| 2PJT | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH WAY-344 |
| 2YIG | A:; B: | MMP13 IN COMPLEX WITH A NOVEL SELECTIVE NON ZINC BINDING INHIBITOR |
| 3ELM | A:; B: | CRYSTAL STRUCTURE OF MMP-13 COMPLEXED WITH INHIBITOR 24F |
| 3I7G | A:; B: | MMP-13 IN COMPLEX WITH A NON ZINC-CHELATING INHIBITOR |
| 3I7I | A:; B: | MMP-13 IN COMPLEX WITH A NON ZINC-CHELATING INHIBITOR |
| 3KEC | A:; B: | CRYSTAL STRUCTURE OF HUMAN MMP-13 COMPLEXED WITH A PHENYL-2H-TETRAZOLE COMPOUND |
| 3KEJ | A:; B: | CRYSTAL STRUCTURE OF HUMAN MMP-13 COMPLEXED WITH A (PYRIDIN-4-YL)-2H-TETRAZOLE COMPOUND |
| 3KEK | A:; B: | CRYSTAL STRUCTURE OF HUMAN MMP-13 COMPLEXED WITH A (PYRIDIN-4-YL)-2H-TETRAZOLE COMPOUND |
| 3KRY | A:; B:; C:; D: | CRYSTAL STRUCTURE OF MMP-13 IN COMPLEX WITH SC-78080 |
| 3LJZ | A:; B:; C:; D: | CRYSTAL STRUCTURE OF HUMAN MMP-13 COMPLEXED WITH AN AMINO-2-INDANOL COMPOUND |
| 3O2X | A:; B:; C:; D: | MMP-13 IN COMPLEX WITH SELECTIVE TETRAZOLE CORE INHIBITOR |
| 3TVC | A: | HUMAN MMP13 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR |
| 3ZXH | A:; B: | MMP-13 COMPLEXED WITH 2-NAPTHYLSULFONAMIDE HYDROXAMIC ACID INHIBITOR |
| 456C | A:; B: | CRYSTAL STRUCTURE OF COLLAGENASE-3 (MMP-13) COMPLEXED TO A DIPHENYL-ETHER SULPHONE BASED HYDROXAMIC ACID |
| 4A7B | A:; B: | MMP13 IN COMPLEX WITH A NOVEL SELECTIVE NON ZINC BINDING INHIBITOR CMPD22 |
| 4JP4 | A:; B: | MMP13 IN COMPLEX WITH A REVERSE HYDROXAMATE ZN-BINDER |
| 4JPA | A:; B: | MMP13 IN COMPLEX WITH A PIPERAZINE HYDANTOIN LIGAND |
| 830C | A:; B: | COLLAGENASE-3 (MMP-13) COMPLEXED TO A SULPHONE-BASED HYDROXAMIC ACID |
)
)